Hemolytic anemia and immune thrombocytopenic purpura were the most common complications of immune checkpoint inhibitor therapy.
For both type 1 and type 2 von Willebrand disease, higher BMI was associated with increased VWF:Ag and FVIII:C levels.
Researchers evaluated response rates to azacitidine and decitabine in patients with chronic myelomonocytic leukemia according to various sets of response criteria.
The FDA has sent an untitled letter to R3 Stem Cell, LLC of Scottsdale, Arizona for marketing unapproved stem cell products to treat a variety of diseases and conditions.
Researchers sought to determine whether disposition and disease severity affected behavioral and cognitive coping strategies in patients with hemophilia.
Researchers recommended performing lactate dehydrogenase level and blood smear testing in patients with renal and neurological symptoms.
Patients who developed cerebrovascular disease following allogeneic hematopoietic stem cell transplantation experienced decreased survival.
In randomized trial, drug demonstrated statistically significant improvement in progression-free survival.
Researchers assessed the predictive value of various laboratory parameters for iron overload in patients with congenital hemolytic anemias.
A bleeding assessment tool yielded higher scores for patients with suspected or confirmed platelet function disorders.
Infants with X-linked severe combined immunodeficiency were found to have fully functioning immune systems following treatment with gene therapy.
Anemia in pregnancy is associated with obstetric and maternal complications, as well as a higher risk for preterm birth for the infant.
Your patients may have questions about leukemia. Help them better understand the condition by sharing this article with them.
In this review, researchers discussed strategies for identifying and treating infection in patients undergoing intensive chemotherapy.
Attending to modifiable risk factors is an important treatment target in patients with atrial fibrillation treated with anticoagulants to reduce thromboembolic and bleeding events.
Almost 20% of refugee children have elevated blood lead levels.
The USPSTF concluded that the current evidence is insufficient to assess the balance of benefits and harms of screening for elevated blood lead levels in asymptomatic children and pregnant women.
The VTE-BLEED risk score identified patients with pulmonary embolism at risk for in-hospital majorbleeding.
The neural network developed in this study yielded a false-negative rate of 0.22%.
Relapse risk increased with cumulative granulocyte colony-stimulating factor dosage but appeared to level out at approximately 75 mg/kg to 100 mg/kg.